Ben Burke

Dr. Ben Burke

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2022 in Brachytherapy
Verified
Journal Article
Closed access
GMGeetha Menon
Geetha Menon
LBLesley Baldwin
Lesley Baldwin
AHAmr A Heikal
Amr A Heikal
BBBen Burke
Ben Burke

31 August 2026 in Current Oncology
Verified
Journal Article
Open access
PDF file
KJKurian Joseph
Kurian Joseph
BBBen Burke
Ben Burke
AHAmr Heikal
Amr Heikal
EYEugene Yip
Eugene Yip
SMShannah Murland
Shannah Murland
BKBeena Kunheri
Beena Kunheri
Pancreatic ductal adenocarcinoma is one of the most aggressive tumours, with an estimated 5-year overall survival rate of 5% and median survival of 5–11 months. Approximately one third of patients die of complications due to local disease progression, especially among patients with borderline resectable or locally advanced disease; hence achieving local control is significant for improved survival outcomes. Stereotactic body radiotherapy (SBRT) allows safe and effective delivery of ablative doses of radiation and is associated with improved locoregional tumour control and progression free survival. Our article describes the rationale and the safe and effective delivery of Linac-based SBRT treatment for pancreatic cancer.

18 April 2024 in Journal of Applied Clinical Medical Physics
Verified
Journal Article
Open access
MRMichael Roumeliotis
Michael Roumeliotis
KTKundan Thind
Kundan Thind
HMHali Morrison
Hali Morrison
BBBen Burke
Ben Burke
KMKevin Martell
Kevin Martell
SQSarah Quirk
Sarah Quirk
Purpose: To demonstrate the impact of implementing hypofractionated prescription regimens and advanced treatment techniques on institutional operational hours and radiotherapy personnel resources in a multi‐institutional setting. The study may be used to describe the impact of advancing the standard of care with modern radiotherapy techniques on patient and staff resources.Methods: This study uses radiation therapy data extracted from the radiotherapy information system from two tertiary care, university‐affiliated cancer centers from 2012 to 2021. Across all patients in the analysis, the average fraction number for curative and palliative patients was reported each year in the decade. Also, the institutional operational treatment hours are reported for both centers. A sub‐analysis for curative intent breast and lung radiotherapy patients was performed to contextualize the impact of changes to imaging, motion management, and treatment technique.Results: From 2012 to 2021, Center 1 had 42 214 patient plans and Center 2 had 43 252 patient plans included in the analysis. Averaged over both centers across the decade, the average fraction number per patient decreased from 6.9 to 5.2 (25%) and 21.8 to 17.2 (21%) for palliative and curative patients, respectively. The operational treatment hours for both institutions increased from 8 h 15 min to 9 h 45 min (18%), despite a patient population increase of 45%.Conclusion: The clinical implementation of hypofractionated treatment regimens has successfully reduced the radiotherapy workload and operational treatment hours required to treat patients. This analysis describes the impact of changes to the standard of care on institutional resources.